Search clinical trials for: SMOFlipid Omegaven

Total 115 results

General University Hospital, Prague
Charles University, Czech Republic; Ministry of Health, Czech Republic

Completed

Crossover Study on the Effect of Omegaven in Combination With Different Lipid Emulsions in Home Parenteral Nutrition

Parenteral Nutrition

Czechia
Johane Allard

Completed

Comparison of Two Intravenous Lipid Emulsions in Home Parenteral Nutrition Patients

Home Parenteral Nutrition

Canada
Children's & Women's Health Centre of British Columbia
Child and Family Research Institute

Unknown

Minimization of IntraLipid Versus Omegaven (MILOve)

Cholestasis | Parenteral Nutrition Associated Liver Disease (PNALD)

Canada
Centre Hospitalier Universitaire de Nice

Completed

Pilot Study: Hepatoprotective Role of SMOFlipid® Used in Short-term Parenteral Nutrition in an Onco-Hematology Pediatric Population (SMOFPILOT)

Dietary and Nutritional Therapies

France
University of Florida

Recruiting

LIPIDS-P Trial Phase I/II (LIPIDS-P)

Septic Shock | Sepsis, Severe

United States
National Taiwan University Hospital

Unknown

Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU.

Critical Ill Patients in SICU

Taiwan
Midwestern Regional Medical Center

Terminated

Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury

Cancer | Hepatic Injury

United States
Jagiellonian University

Completed

The Impact of the Type and Route of Nutritional Support on Infectious Complications After Upper Gastrointestinal Surgery

Gastrointestinal Surgery

Poland
Dr. Soetomo General Hospital

Completed

Impact of Fish Oil-enriched Lipid Emulsion on Fatty Acid and Inflammatory Response in Infants After Surgery

Surgery

Indonesia
Fresenius Kabi

Not yet recruiting

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

Malnutrition | Malnutrition, Child

United States
Assiut University

Not yet recruiting

Lipid Emulsion in Cardiac Valve Replacement Surgery

Ischemic Reperfusion Injury
Mansoura University Children Hospital

Completed

The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis

Sepsis Newborn

Egypt
Li Shin Hospital

Completed

Clinical Assessment of Fish Oil-based Lipid Emulsion Infusions in Critical Patients With Severe Sepsis

Severe Sepsis

Taiwan
National Taiwan University Hospital

Completed

Efficacy and Safety Comparison Between SMOFlipid and Lipovenoes MCT

Malnutrition | Gastrectomy

Taiwan
Carle Foundation Hospital

Unknown

Omegaven® as Parenteral Nutrition

Cholestasis

United States
Mayo Clinic

Withdrawn

SMOFLipid in Patients Who Are Intralipid Intolerant

Short Bowel Syndrome | Home Parenteral Nutrition

United States
Hospices Civils de Lyon

Withdrawn

Rate of Bronchopulmonary Dysplasia in Preterms Neonates: a Trial Comparing SMOFlipid and Medialipide (SMOF)

Preterm Neonates

France
Medical University of Vienna

Completed

Preventing Cholestasis Using SMOFLipid®

Cholestasis | Psychomotor Disorders, Developmental

Austria
Mark Puder

Completed

Cholestasis Reversal: Efficacy of IV Fish Oil (Reversal)

Gastrointestinal Disease | Short Bowel Syndrome | Parenteral Nutrition Associated Liver Disease

United States
Mayo Clinic

Active, not recruiting

Intralipid Versus SMOFlipid in HPN Patients

Crohn Disease | Intestinal Fistula | Intestinal Obstruction | Short Bowel Syndrome

United States
Mansoura University

Unknown

Lipids and Neurological Complications in Liver Transplantation (LNCLT)

Neurological Complications

Egypt
Klinikum Ludwigshafen

Completed

Influence of of a Lipid Emulsion on Inflammatory Response and Hepatic Function

Inflammatory Response | Hepatic Function

Germany
DHR Health Institute for Research and Development

Approved for marketing

Omegaven Protocol:Intermediate Size Patient Population

Parenteral Nutrition Associated Liver Disease
Rush University Medical Center

Approved for marketing

Intravenous Fish Oils in the Treatment of Parenteral Nutrition Liver Injury

Cholestasis | Total Parenteral Nutrition-induced Cholestasis

United States
Fresenius Kabi

Terminated

Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age

Malnutrition, Child

United States
Coordinación de Investigación en Salud, Mexico
University of Southampton; Universidad Nacional Autonoma de Mexico

Enrolling by invitation

Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH (CDH-PPHN-N3)

Pulmonary Hypertension of Newborn | Diaphragm Defect

Mexico
Arthur J De Lorimier

Completed

Compassionate Use of an Intravenous Fish Oil Emulsion in Infants With Cholestasis

Parenteral Nutrition Associated Cholestasis

United States
University of South Florida

Completed

Omegaven as Alternative Parenteral Fat Nutrition

Cholestasis | Cholestasis of Parenteral Nutrition

United States
University of California, Los Angeles

Terminated

A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease (FO)

Cholestasis

United States
St. Luke's Health System, Boise, Idaho

No longer available

Omegaven Expanded Access Protocol

Parenteral Nutrition Associated Liver Disease

United States
Catherine Cibulskis, MD
St. Louis University

Approved for marketing

Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease

Liver Diseases | Cholestasis

United States
Cindy Haller

Terminated

Compassionate Use of Omegaven IV Fat Emulsion

Cholestasis | Total Parenteral Nutrition-induced Cholestasis

United States
Fresenius Kabi

Not yet recruiting

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Malnutrition | Pediatric ALL | Essential Fatty Acid Deficiency | Parenteral Nutrition Associated Liver Disease (PNALD)
Children's Hospital Los Angeles

Completed

Omegaven Treatment of Parenteral Nutrition (PN) Induced Liver Injury

Liver Injury

United States
The Hospital for Sick Children
Fresenius Kabi

Unknown

Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?

Short Bowel Syndrome | Intestinal Failure | Gastrointestinal Motility Disorder | Mucosal Enteropathy

Canada
Fresenius Kabi

Withdrawn

Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)

Malnutrition | Pediatric ALL | Neurocognitive Deficit | Parenteral Nutrition Associated Liver Disease | Essential Fatty Acid Deficiency
Children's Hospital Medical Center, Cincinnati

Completed

Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis

Cholestasis

United States
Georgetown University

Approved for marketing

Safer Parenteral Nutrition in Pediatric Short Bowel Syndrome to Decrease Liver Damage

Cholestasis of Parenteral Nutrition

United States
University of California, San Diego

No longer available

Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis

Cholestasis

United States
Geisinger Clinic

Approved for marketing

Compassionate Use of Omegaven

Cholestasis
Nizam's Institute of Medical Sciences University...

Completed

Preoperative Intravenous Omega 3 Fatty Acids Administration in Elderly Patients Undergoing Hip Surgery

Hip Surgery

India
Amarnath, Rathna, M.D.

Unknown

Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease

Cholestasis | Short Bowel Syndrome

United States
Fresenius Kabi

Terminated

Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants

Hospitalized Neonates and Infants, Expected to Require Parenteral Nutrition for 28 Days

United States
Giulia Manzini

Recruiting

Diagnostic Role of the "White Test" With Lipidic Solution in the Early Intraoperative Identification of Open Bile Ducts for the Prevention of Bile Leakage After Liver Resection (BiLe -Trial) (BiLe)

Bile Leakage

Switzerland
Stanley Dudrick's Memorial Hospital

Completed

High Dose Intravenous Fish Oil Reduces Inflammation

Lipid Metabolism Disorders

Poland
University Hospital Inselspital, Berne

Completed

Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies (LUNCH1)

Colitis | AML | Mucositis

Switzerland
Children's Hospital of Philadelphia

Approved for marketing

Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease (Omegaven)

Cholestasis | Short Bowel Syndrome

United States
Children's Medical Center Dallas

Completed

Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury

Liver Disease | Parenteral Nutrition Associated Liver Disease | Impaired Liver Function

United States
Northwell Health

No longer available

Compassionate Use of Omegaven IV Fat Emulsion

Liver Disease | Cholestasis

United States
Mansoura University

Unknown

Omega 3 Lipid Emulsions and Liver Transplantation (OTLT)

Ischemia Re-perfusion Injury

Egypt

Search clinical trials for: SMOFlipid Omegaven

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations